Form 4: Boston Scientific EVP and CFO Daniel J. Brennan Reports Stock Transactions

Daniel J. Brennan, EVP and CFO of Boston Scientific, reports the vesting of restricted stock units and subsequent tax withholding.

Summary

• On February 12, 2025, Daniel J. Brennan, EVP and CFO of Boston Scientific, reported transactions involving Boston Scientific common stock.
• Brennan vested 3,654 restricted stock units, each representing the right to receive one share of Boston Scientific common stock.
• These restricted stock units vested on February 12, 2025.
• Also on February 12, 2025, 1,767 shares were withheld to cover tax obligations at a price of $105.77 per share.
• Following these transactions, Brennan directly owns 243,338 shares of Boston Scientific common stock and 10,963 restricted stock units.
• The restricted stock units will be issued in four equal annual installments beginning on February 12, 2025.

Sentiment

Score: 5

Explanation: This is a routine filing related to executive compensation, with no particularly positive or negative implications.

Future Outlook

Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.

Industry Context

This is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Stakeholder Impact

• The transaction affects the executive's holdings in the company, which may be of interest to shareholders.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Transaction, Restricted Stock Units, Daniel J. Brennan, Boston Scientific, BSX, CFO